Mortality in patients with metabolic syndrome during the COVID-19 pandemic: a systematic review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Anais da Faculdade de Medicina de Olinda (Online) |
Texto Completo: | https://afmo.emnuvens.com.br/afmo/article/view/208 |
Resumo: | The COVID-19 pandemic, responsible for the biggest health crisis today, is a serious public health problem worldwide. Metabolic comorbidities, such as type 2 diabetes, hypertension and obesity, characterize the metabolic syndrome, and have been associated with severe forms of the disease and death. We investigated mortality in patients with COVID-19 and its association with metabolic diseases. This is a systematic review following the PRISMA recommendation. Cohort, case-control and cross-sectional studies were considered. The MEDLINE/EBSCO, Cochrane Library, Pubmed and SciELO databases were consulted using strategies limited to English, Spanish and Portuguese, between January 2020 and March 2021. From this search, 14 articles were included. Most studies were published on the Medline platform (64.3%), in English (93%), cohort studies (57%). Around 60% of the population of the selected studies consisted of men and the mean age was 58 years. Approximately 20% of the total population of the studies had hypertension (25.8%), obesity (20.5%) and diabetes (19.1%) as comorbity. The mortality rate among those was 12.5%. The presence of metabolic comorbidities constituted factors associated with mortality in patients with COVID-19. Future studies are needed to accurately determine the pathogenic mechanism involving these patients, especially hypertensive, diabetic and obese men, and the development of severe forms of COVID-19 infection. |
id |
FMO-1_2b7cea97c166d34b7228531387e70581 |
---|---|
oai_identifier_str |
oai:ojs.afmo.emnuvens.com.br:article/208 |
network_acronym_str |
FMO-1 |
network_name_str |
Anais da Faculdade de Medicina de Olinda (Online) |
repository_id_str |
|
spelling |
Mortality in patients with metabolic syndrome during the COVID-19 pandemic: a systematic reviewMortalidade em pacientes com síndrome metabólica durante a pandemia de COVID-19: uma revisão sistemáticaSíndrome MetabólicaInfecção por CoronavirusTranstornos do Metabolismo da GlicoseObesidadecomplicaçõesmortalidadeMetabolic SyndromeCoronavirus InfectionsGlucose Metabolism DisordersObesityComplicationsMortalityThe COVID-19 pandemic, responsible for the biggest health crisis today, is a serious public health problem worldwide. Metabolic comorbidities, such as type 2 diabetes, hypertension and obesity, characterize the metabolic syndrome, and have been associated with severe forms of the disease and death. We investigated mortality in patients with COVID-19 and its association with metabolic diseases. This is a systematic review following the PRISMA recommendation. Cohort, case-control and cross-sectional studies were considered. The MEDLINE/EBSCO, Cochrane Library, Pubmed and SciELO databases were consulted using strategies limited to English, Spanish and Portuguese, between January 2020 and March 2021. From this search, 14 articles were included. Most studies were published on the Medline platform (64.3%), in English (93%), cohort studies (57%). Around 60% of the population of the selected studies consisted of men and the mean age was 58 years. Approximately 20% of the total population of the studies had hypertension (25.8%), obesity (20.5%) and diabetes (19.1%) as comorbity. The mortality rate among those was 12.5%. The presence of metabolic comorbidities constituted factors associated with mortality in patients with COVID-19. Future studies are needed to accurately determine the pathogenic mechanism involving these patients, especially hypertensive, diabetic and obese men, and the development of severe forms of COVID-19 infection.A pandemia do COVID-19, responsável pela maior crise sanitária da atualidade, constitui um grave problema de saúde pública mundial. Comorbidades metabólicas, a exemplo da diabetes mellitus tipo 2, hipertensão arterial e obesidade, caracterizam a síndrome metabólica, e têm sido associadas às formas graves da doença e óbito. Investigamos a mortalidade em pacientes com COVID-19 e a sua associação com doenças metabólicas. Trata-se de uma revisão sistemática seguindo a recomendação PRISMA. Foram considerados estudos de coorte, caso-controle e corte seccional. As bases de dados MEDLINE/EBSCO, Cochrane Library, Pubmed e SciELO foram consultadas por meio das estratégias limitadas aos idiomas inglês, espanhol e português, no período entre janeiro de 2020 e março de 2021. A partir desta busca, 14 artigos foram incluídos. A maioria dos estudos foi publicado na plataforma Medline (64,3%), em inglês (93%), do tipo coorte (57%). Em torno de 60% da população dos estudos selecionados foi constituída por homens e a média de idade foi de 58 anos. Observou-se que aproximadamente 20% da população total dos estudos apresentavam hipertensão (25,8%), obesidade (20,5%) e diabetes (19,1%). A taxa de mortalidade entre eles foi de 12,5%. A presença de comorbidades metabólicas constituíram fatores associados à mortalidade em pacientes com COVID-19. Estudos futuros são necessários para determinar com precisão o mecanismo patogênico que envolve esses pacientes, especialmente homens hipertensos, diabéticos e obesos, e o desenvolvimento das formas graves da infecção por COVID-19.Faculdade de Medicina de Olinda2022-12-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://afmo.emnuvens.com.br/afmo/article/view/20810.56102/afmo.2022.208ANNALS OF OLINDA MEDICAL SCHOOL; Vol. 1 No. 8 (2022); 7-17Anais da Faculdade de Medicina de Olinda; v. 1 n. 8 (2022); 7-172674-84872595-1734reponame:Anais da Faculdade de Medicina de Olinda (Online)instname:Faculdade de Medicina de Olinda (FMO)instacron:FMOporhttps://afmo.emnuvens.com.br/afmo/article/view/208/120Copyright (c) 2022 Carolline Araujo, Elisabeth Uchoa de Melo, Érika Thienne Lopes da Silva, Gabriela de Sousa Carballosa González, José Kaellyson Barbosa dos Santos Oliveira, Luciana Andrade Tavareshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessUchoa de Melo, Elisabeth Lopes da Silva, Érika Thienne de Sousa Carballosa González, GabrielaBarbosa dos Santos Oliveira, José KaellysonAndrade Tavares, LucianaAraujo, Carolline2023-01-25T14:16:07Zoai:ojs.afmo.emnuvens.com.br:article/208Revistahttps://afmo.emnuvens.com.br/afmoPUBhttps://afmo.emnuvens.com.br/afmo/oaianaisfmo@fmo.edu.br2674-84872595-1734opendoar:2023-01-25T14:16:07Anais da Faculdade de Medicina de Olinda (Online) - Faculdade de Medicina de Olinda (FMO)false |
dc.title.none.fl_str_mv |
Mortality in patients with metabolic syndrome during the COVID-19 pandemic: a systematic review Mortalidade em pacientes com síndrome metabólica durante a pandemia de COVID-19: uma revisão sistemática |
title |
Mortality in patients with metabolic syndrome during the COVID-19 pandemic: a systematic review |
spellingShingle |
Mortality in patients with metabolic syndrome during the COVID-19 pandemic: a systematic review Uchoa de Melo, Elisabeth Síndrome Metabólica Infecção por Coronavirus Transtornos do Metabolismo da Glicose Obesidade complicações mortalidade Metabolic Syndrome Coronavirus Infections Glucose Metabolism Disorders Obesity Complications Mortality |
title_short |
Mortality in patients with metabolic syndrome during the COVID-19 pandemic: a systematic review |
title_full |
Mortality in patients with metabolic syndrome during the COVID-19 pandemic: a systematic review |
title_fullStr |
Mortality in patients with metabolic syndrome during the COVID-19 pandemic: a systematic review |
title_full_unstemmed |
Mortality in patients with metabolic syndrome during the COVID-19 pandemic: a systematic review |
title_sort |
Mortality in patients with metabolic syndrome during the COVID-19 pandemic: a systematic review |
author |
Uchoa de Melo, Elisabeth |
author_facet |
Uchoa de Melo, Elisabeth Lopes da Silva, Érika Thienne de Sousa Carballosa González, Gabriela Barbosa dos Santos Oliveira, José Kaellyson Andrade Tavares, Luciana Araujo, Carolline |
author_role |
author |
author2 |
Lopes da Silva, Érika Thienne de Sousa Carballosa González, Gabriela Barbosa dos Santos Oliveira, José Kaellyson Andrade Tavares, Luciana Araujo, Carolline |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Uchoa de Melo, Elisabeth Lopes da Silva, Érika Thienne de Sousa Carballosa González, Gabriela Barbosa dos Santos Oliveira, José Kaellyson Andrade Tavares, Luciana Araujo, Carolline |
dc.subject.por.fl_str_mv |
Síndrome Metabólica Infecção por Coronavirus Transtornos do Metabolismo da Glicose Obesidade complicações mortalidade Metabolic Syndrome Coronavirus Infections Glucose Metabolism Disorders Obesity Complications Mortality |
topic |
Síndrome Metabólica Infecção por Coronavirus Transtornos do Metabolismo da Glicose Obesidade complicações mortalidade Metabolic Syndrome Coronavirus Infections Glucose Metabolism Disorders Obesity Complications Mortality |
description |
The COVID-19 pandemic, responsible for the biggest health crisis today, is a serious public health problem worldwide. Metabolic comorbidities, such as type 2 diabetes, hypertension and obesity, characterize the metabolic syndrome, and have been associated with severe forms of the disease and death. We investigated mortality in patients with COVID-19 and its association with metabolic diseases. This is a systematic review following the PRISMA recommendation. Cohort, case-control and cross-sectional studies were considered. The MEDLINE/EBSCO, Cochrane Library, Pubmed and SciELO databases were consulted using strategies limited to English, Spanish and Portuguese, between January 2020 and March 2021. From this search, 14 articles were included. Most studies were published on the Medline platform (64.3%), in English (93%), cohort studies (57%). Around 60% of the population of the selected studies consisted of men and the mean age was 58 years. Approximately 20% of the total population of the studies had hypertension (25.8%), obesity (20.5%) and diabetes (19.1%) as comorbity. The mortality rate among those was 12.5%. The presence of metabolic comorbidities constituted factors associated with mortality in patients with COVID-19. Future studies are needed to accurately determine the pathogenic mechanism involving these patients, especially hypertensive, diabetic and obese men, and the development of severe forms of COVID-19 infection. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-12-22 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://afmo.emnuvens.com.br/afmo/article/view/208 10.56102/afmo.2022.208 |
url |
https://afmo.emnuvens.com.br/afmo/article/view/208 |
identifier_str_mv |
10.56102/afmo.2022.208 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://afmo.emnuvens.com.br/afmo/article/view/208/120 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Faculdade de Medicina de Olinda |
publisher.none.fl_str_mv |
Faculdade de Medicina de Olinda |
dc.source.none.fl_str_mv |
ANNALS OF OLINDA MEDICAL SCHOOL; Vol. 1 No. 8 (2022); 7-17 Anais da Faculdade de Medicina de Olinda; v. 1 n. 8 (2022); 7-17 2674-8487 2595-1734 reponame:Anais da Faculdade de Medicina de Olinda (Online) instname:Faculdade de Medicina de Olinda (FMO) instacron:FMO |
instname_str |
Faculdade de Medicina de Olinda (FMO) |
instacron_str |
FMO |
institution |
FMO |
reponame_str |
Anais da Faculdade de Medicina de Olinda (Online) |
collection |
Anais da Faculdade de Medicina de Olinda (Online) |
repository.name.fl_str_mv |
Anais da Faculdade de Medicina de Olinda (Online) - Faculdade de Medicina de Olinda (FMO) |
repository.mail.fl_str_mv |
anaisfmo@fmo.edu.br |
_version_ |
1796798260566818816 |